MARKET

ABBV

ABBV

Abbvie Inc
NYSE
227.91
+1.09
+0.48%
After Hours: 225.95 -1.96 -0.86% 19:43 12/22 EST
OPEN
226.11
PREV CLOSE
226.82
HIGH
228.65
LOW
224.25
VOLUME
4.83M
TURNOVER
--
52 WEEK HIGH
243.06
52 WEEK LOW
160.33
MARKET CAP
402.80B
P/E (TTM)
171.97
1D
5D
1M
3M
1Y
5Y
1D
Lyell Immunopharma pops on recent ASH data, immunotherapy expansion
Seeking Alpha · 12h ago
Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends
NASDAQ · 13h ago
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
The Motley Fool · 22h ago
Weekly Report: what happened at ABBV last week (1215-1219)?
Weekly Report · 23h ago
Does OSE’s ABBV-230 Shift Reveal a Deeper Risk-Sharing Strategy in AbbVie’s Immunology Pipeline (ABBV)?
Simply Wall St · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN)
TipRanks · 1d ago
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal
Benzinga · 3d ago
Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts
Benzinga · 3d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.